Literature DB >> 25194807

Interleukin-27 inhibits foam cell formation by promoting macrophage ABCA1 expression through JAK2/STAT3 pathway.

Hui Fu1, Yan-Yan Tang2, Xin-Ping Ouyang2, Shi-Lin Tang1, Hua Su1, Xiaotao Li1, Li-Ping Huang1, Miao He1, Yun-Cheng Lv2, Ping-Ping He2, Feng Yao2, Yu-Lin Tan2, Wei Xie2, Min Zhang2, Jianfeng Wu3, Yuan Li2, Kong Chen3, Dan Liu2, Gang Lan2, Meng-Ya Zeng3, Xi-Long Zheng4, Chao-Ke Tang5.   

Abstract

The purpose of this study is to determine whether IL-27 regulates macrophage ABCA1 expression, foam cell formation, and also explore the underlying mechanisms. Here, we revealed that IL-27 decreased lipid accumulation in THP-1 derived macrophages through markedly enhancing cholesterol efflux and increasing ABCA1 expression at both protein and mRNA levels. Our study further demonstrated that IL-27 increased ABCA1 level via activation of signal transducer and activator of transcription 3 (STAT3). Inhibition of Janus kinase 2, (JAK2)/STAT3 suppressed the stimulatory effects of IL-27 on ABCA1 expression. The present study concluded that IL-27 reduces lipid accumulation of foam cell by upregulating ABCA1 expression via JAK2/STAT3. Therefore, targeting IL-27 may offer a promising strategy to treat atherosclerotic vascular disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP-binding cassette transporter A1; Foam cell; Interleukin-27; Janus kinase 2; Signal transducer and activator of transcription 3

Mesh:

Substances:

Year:  2014        PMID: 25194807     DOI: 10.1016/j.bbrc.2014.08.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Macrophage-activating lipopeptide-2 downregulates the expression of ATP-binding cassette transporter A1 by activating the TLR2/NF-кB/ZNF202 pathway in THP-1 macrophages.

Authors:  Liangjie Peng; Zizhen Zhang; Min Zhang; Xiaohua Yu; Feng Yao; Yulin Tan; Dan Liu; Duo Gong; Huang Chong; Xiaoyan Liu; Xilong Zheng; Guoping Tian; Chaoke Tang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

2.  Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.

Authors:  Ida Gregersen; Øystein Sandanger; Erik T Askevold; Ellen Lund Sagen; Kuan Yang; Sverre Holm; Turid M Pedersen; Mona Skjelland; Kirsten Krohg-Sørensen; Trond Vidar Hansen; Tuva Børresdatter Dahl; Kari Otterdal; Terje Espevik; Pål Aukrust; Arne Yndestad; Bente Halvorsen
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

3.  An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway.

Authors:  Xin Xu; Kunkun Han; Jingyu Zhu; Hongwu Mao; Xu Lin; Zubin Zhang; Biyin Cao; Yuanying Zeng; Xinliang Mao
Journal:  Oncotarget       Date:  2016-11-15

4.  Predicting dyslipidemia after liver transplantation: A significant role of recipient metabolic inflammation profile.

Authors:  Hai-Tao Huang; Xue-You Zhang; Cheng Zhang; Qi Ling; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

Review 5.  Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Authors:  Dmitry Y Litvinov; Eugeny V Savushkin; Alexander D Dergunov
Journal:  Pharmaceut Med       Date:  2019-12

6.  Interleukin-27 decreases ghrelin production through signal transducer and activator of transcription 3-mechanistic target of rapamycin signaling.

Authors:  Heng Zhang; Qingjie Li; Yuxin Teng; Yubi Lin; Shaojian Li; Tingfeng Qin; Linxi Chen; Jiana Huang; Hening Zhai; Quan Yu; Geyang Xu
Journal:  Acta Pharm Sin B       Date:  2020-01-07       Impact factor: 11.413

Review 7.  Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis.

Authors:  Joselyn Rojas; Juan Salazar; María Sofía Martínez; Jim Palmar; Jordan Bautista; Mervin Chávez-Castillo; Alexis Gómez; Valmore Bermúdez
Journal:  Scientifica (Cairo)       Date:  2015-09-27

8.  Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.

Authors:  Fangchen Gong; Jin Wu; Ping Zhou; Mengyao Zhang; Jingning Liu; Ying Liu; Xiang Lu; Zhengxia Liu
Journal:  Mediators Inflamm       Date:  2016-10-18       Impact factor: 4.711

Review 9.  Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and - independent signaling pathways with relevance to inflammatory lung disease.

Authors:  Patrick He; Ingrid C Gelissen; Alaina J Ammit
Journal:  Respir Res       Date:  2020-09-25

10.  CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced STAT3 activation.

Authors:  Shijun Yu; Jingde Chen; Ming Quan; Li Li; Yandong Li; Yong Gao
Journal:  J Cell Mol Med       Date:  2020-12-04       Impact factor: 5.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.